Related by context. All words. (Click for frequent words.) 73 anti CD# antibody 70 chimeric monoclonal antibody 69 humanized antibody 68 immunotoxin 68 replicon 68 targeted antifolate 68 targeting CD# 67 CD# monoclonal antibody 67 stable linker 67 humanized anti 67 drug conjugate 67 recombinant fusion 67 Vaccine Adjuvant 67 Fresenius Biotech 67 orally administered inhibitor 67 rxRNA 67 drug conjugate ADC 67 non nucleoside inhibitor 67 proteasome inhibitor 66 Roche SIX RO 66 IMA# 66 anti CD3 monoclonal 66 immune modulatory 66 monoclonal antibody mAb 66 MAGE A3 ASCI 66 ActA 66 Recombinant Human 66 cleavable linker 66 investigational humanized monoclonal antibody 66 humanized monoclonal 66 potent cytotoxic 66 BiTE R 66 GVAX ® 66 Immunotherapeutic 66 Thiovir 66 Epratuzumab 66 immatics 66 refractory chronic lymphocytic 66 Granulocyte Colony Stimulating Factor 66 virosome 65 TLR9 agonists 65 therapeutic monoclonal antibodies 65 bispecific 65 BiTE ® 65 OncoVEX 65 recombinant adeno associated 65 Potelligent Technology 65 FOLOTYN ® 65 MKC# MT 65 Personalized Immunotherapy 65 immunomodulatory properties 65 histone deacetylase inhibitor 65 liposomal formulation 65 Fc fusion protein 65 attach auristatin 65 SynCon 65 therapeutic monoclonal antibody 65 Maribavir 65 Initiates Clinical 65 BAL# [001] 65 Gamunex C 65 Tezampanel 65 Kiadis 65 A3 adenosine receptor 65 MMAE 65 Zenyaku Kogyo 65 OncoVex 65 anti CD3 65 IMiDs ® compound 65 Epidermal Growth Factor Receptor 65 Evoltra ® 65 immune modulating 65 HCV protease inhibitor 65 IMiDs R 65 Monoclonal antibody 65 vapreotide acetate 65 TLR9 agonist 65 mertansine 65 Plasmid DNA 65 LymphoStat B belimumab 65 antibody MAb 64 peptidic compound 64 humanized monoclonal antibodies 64 agonistic human 64 anti CD# antibodies 64 Monoclonal Antibody 64 drug conjugates ADCs 64 PDE4 inhibitor 64 CYC# 64 MT#/MEDI-# 64 YONDELIS 64 intranasal formulation 64 human IgG1 monoclonal 64 somatostatin analogue 64 Intravenous Human 64 peptibody 64 PEGylated interferon 64 protein tyrosine phosphatase 1B 64 Ceflatonin 64 PEGylated 64 virus AAV 64 RECOTHROM R 64 IAP inhibitors 64 Valopicitabine 64 etanercept Enbrel 64 liposomal delivery 64 Aviptadil 64 oncolytic 64 oral proteasome inhibitor 64 Initiates Phase II 64 orally bioavailable mimics 64 Antiangiogenic 64 soluble tumor necrosis 64 immunostimulatory 64 vinca alkaloid 64 ALN HPN 64 CD# CEA 64 Trastuzumab DM1 64 HCV polymerase 64 hyaluronidase enzyme 64 JAK2 inhibitor 64 Litx 64 transthyretin TTR 64 HuMax TAC 64 oral prodrug 64 Ridaforolimus 64 Pertuzumab 64 Medarex UltiMAb R 64 IgG1 monoclonal antibody 64 recombinant subunit vaccine 64 antibody MT# 64 oncolytic virus therapies 64 Protein Kinase C 64 PKC# 64 CYT# potent vascular disrupting 64 Virulizin ® 64 selective orally bioavailable 64 Scancell 63 ATL# [001] 63 HuLuc# 63 PNP inhibitor 63 RECOTHROM ® 63 Tarvacin TM 63 Micromet BiTE 63 Adenosine Therapeutics 63 Zorbtive TM 63 miRNA therapeutics 63 GTC recombinant human 63 Kinase Inhibitor 63 antisense inhibitor 63 investigational monoclonal antibody 63 Taiho Pharmaceutical 63 IAP inhibitor 63 pan HDAC inhibitor 63 JAK2 Inhibitor 63 GTC recombinant form 63 YONDELIS R 63 Epiphany Biosciences 63 small molecule thrombopoietin 63 Panzem R 63 oral antiviral 63 MVA BN R 63 meropenem 63 selective inhibition 63 NASDAQ ABII 63 RNAi therapeutic targeting 63 PI3K/Akt pathway inhibitor 63 apricitabine ATC 63 TRX1 63 siRNAs targeting 63 Elvitegravir 63 Payload TAP technology 63 phosphatidylserine PS targeting 63 murine monoclonal antibody 63 acetonide FA 63 lipid nanoparticle 63 Epothilones 63 VivaGel ™ 63 Completes Patient Enrollment 63 thetreatment 63 mTOR mammalian target 63 Bendamustine 63 potent antiproliferative 63 kidney urologic 63 Receives Orphan Drug Designation 63 MyVax R 63 trastuzumab DM1 T DM1 63 ChronVac C 63 VitiGam 63 developing Bicifadine serotonin 63 SAR# [002] 63 Anticalins ® 63 Argatroban 63 Vaccinex 63 XL# anticancer compounds 63 NXL# 63 POTELLIGENT ® 63 antibody fragment 63 HyperAcute 63 Yondelis ® 63 Azacitidine 63 OTCBB HXBM developer 63 HCV NS3 protease 63 Fludara ® 63 Chemokine Receptor 63 Antitumor 63 Daclizumab 63 JAK3 63 adenosine A2A 63 Vegenics 63 G#DT 63 Onalta 63 GRNVAC1 63 binds selectively 63 Bavituximab 63 Spiegelmers 63 PentaStaph 63 Cathepsin S 63 herpes simplex viruses 63 SNT MC# 63 selective modulator 63 Inovio Pharmaceuticals 63 CCR5 receptor antagonist 63 Presents Preclinical 63 potent topoisomerase II 63 evaluating tivozanib 63 Presents Preclinical Data 63 humanised monoclonal antibody 63 FGFR 63 novel immunotherapeutic 63 adecatumumab MT# 63 SPRYCEL ® 63 targeted radiotherapeutic 63 Sphingomab 63 P#X# antagonist 63 Vernalis plc 63 IMiDs ® 63 methylnaltrexone bromide 63 Elotuzumab 63 Alvesco R 63 NPM1 63 MVA BN 63 mda 7 63 #T# tumor 63 proprietary polysaccharide 63 Bazedoxifene 63 benzimidazole 63 novel peptides 63 SCIB1 63 alpha folate receptor 62 Initiates Enrollment 62 anticancer therapeutics 62 selective kinase inhibitor 62 Zalypsis 62 TransVax tm 62 Tibotec BVBA 62 include Altastaph TM 62 selective immunoproteasome inhibitor 62 ProtAffin 62 myelofibrosis polycythemia vera 62 AVP #D# 62 Ganciclovir 62 MCSP respectively 62 Epitomics 62 cathepsin K inhibitor 62 ONCASPAR 62 accumulate preferentially 62 Thrombin topical Recombinant 62 Crofelemer budesonide foam 62 virus HCV protease inhibitor 62 MGd 62 SynCon ™ DNA 62 vascular disrupting agents 62 NS#/#A protease 62 Dendritic Cell 62 Prestara 62 TRACON Pharmaceuticals 62 5 HT2A serotonin 62 NTDDS 62 cilengitide 62 monoclonal anti 62 Completes Dosing 62 potently inhibit 62 POTELLIGENT R 62 VaxImmune 62 Therapeutic Competitors companiesandmarkets.com adEgemonye 62 XL# XL# 62 BAL# [002] 62 AEG# 62 ceftazidime 62 SMaRT ™ 62 SAR# [004] 62 K RAS 62 Initiate Clinical Trial 62 CCR9 antagonist 62 CD# antibody [001] 62 Hsp# Inhibitor 62 Civacir 62 Gleevec resistant 62 immunomodulator 62 Atripla combines 62 anti EGFR antibody 62 beta 1a 62 BARACLUDE R 62 Vidaza R 62 immunotherapeutic vaccine 62 AGS PSCA 62 proprietary BiTE R 62 Tiuxetan 62 Opterone R 62 entinostat 62 novel emulsion formulation 62 pediatric acute lymphoblastic 62 Loramyc 62 Receives Orphan Drug 62 polyglutamate 62 IV Busulfex 62 microtubule inhibitor 62 plasmid encoding 62 Japanese Encephalitis Vaccine 62 investigational immunotherapy 62 Telatinib 62 HuMax 62 Virosome Biologicals 62 metaglidasen 62 Kuvan sapropterin dihydrochloride 62 JAK1 62 vidofludimus 62 anticancer agent 62 OXIGON TM 62 HTS assay 62 LymphoStat B TM 62 Marqibo TM 62 small molecule glucokinase 62 GV# [001] 62 HCV RNA polymerase 62 thalidomide Thalomid 62 OTCBB PYTO 62 transfection reagents 62 Xanafide 62 CRTH2 62 acid phosphatase PAP 62 humanized monoclonal antibody 62 Aurora Kinase 62 antisense inhibitors 62 Oxis International 62 Kahalalide F 62 Therapeutic Competitors Companies 62 Factor VIIa 62 Onconase 62 PrevOnco 62 MKC# MKC# PP 62 HGS ETR2 62 Guanilib 62 Methylnaltrexone 62 mediate antibody 62 MOVIPREP R 62 NS5b 62 Euroscreen 62 IMC #B 62 lexidronam injection 62 Anticalins R 62 SinuNase ™ 62 candidate deforolimus 62 DNA intercalator 62 novel therapeutic antibodies 62 Virulizin R 62 Nexavar ® 62 Affitech AS 62 monoclonal antibody conjugated 62 PROSTASCINT R 62 Reports Preclinical Data 62 Novel Oral 62 Genentech Rituxan 62 immunotherapeutics 62 Calixa 62 VEGF receptor 62 Ceflatonin R 62 Nanobody 62 Alfacell proprietary ribonuclease 62 Monoclonal 62 MedPulser 62 potent inhibitory 62 Cytotoxic T 62 Orally administered 62 Pralatrexate 62 HGS ETR1 mapatumumab 62 immunomodulating 62 Meets Primary Endpoint 62 DeveloGen 61 ADP receptor antagonist 61 ALN TTR 61 proprietary BiTE ® 61 Arno Therapeutics 61 auristatin 61 tumor vascular disrupting 61 Vion Pharmaceuticals 61 depsipeptide 61 Files IND 61 Rituxan rituximab 61 Nanobody R 61 antitumoral 61 UPLYSO 61 hypereosinophilic syndrome 61 NPC 1C 61 Small Molecule 61 small molecule Hedgehog 61 Phase 2b Clinical Trial 61 ArQule Kinase Inhibitor Platform 61 synthetic peptide containing 61 PEGylated Fab fragment 61 Liposomal 61 Locked Nucleic Acid 61 Tumor Necrosis Factor 61 receptor inhibitor 61 recombinant FVIII 61 Genotyping Test 61 drug pipeline TAFA# 61 HuCAL antibody 61 developing Zerenex ferric 61 cMet 61 dependent cellular cytotoxicity 61 poly ADP ribose polymerase 61 UniBody 61 epothilones 61 ospemifene 61 oncolytic virus 61 DP VPA 61 conserved antigens NP 61 Pazopanib 61 paclitaxel Taxol ® 61 Aurora kinase inhibitor 61 fibrosis IPF 61 DepoDur 61 CureDM 61 PANC 61 Olaparib 61 HuMax CD4 61 Onalta TM 61 XmAb# 61 LUCASSIN 61 zanolimumab 61 nicotinic alpha 7 61 JAK inhibitors 61 PGL# 61 fusion proteins 61 OMRIX Biopharmaceuticals Inc. 61 antisense oligonucleotide 61 SMARTICLES ® 61 CDP# 61 Leukine ® 61 BCR ABL inhibitors 61 GlycArt 61 Enkephalin 61 Insegia 61 telaprevir VX 61 tyrosine kinase receptor 61 lumiliximab 61 orthopoxvirus 61 Successfully Completes Phase 61 protein kinase inhibitor 61 erlotinib Tarceva ® 61 Septin9 biomarker 61 interleukin IL -# 61 adult mesenchymal stem 61 immunoconjugate 61 REGiMMUNE 61 HCV replicon 61 fusion inhibitor 61 EHT AGN 61 Temsirolimus 61 cetuximab Erbitux R 61 tranilast 61 HuCAL GOLD R 61 Micromet proprietary BiTE 61 Dalbavancin 61 Hybridon 61 tests miRview TM 61 thrombin receptor 61 Vaxfectin ® 61 Locked Nucleic Acid LNA 61 IL #E 61 Peginterferon alfa 2b 61 Belerofon 61 biologic therapeutics 61 MBRX 61 RNAi Therapeutic 61 Tarvacin 61 Omacetaxine 61 histone deacetylase HDAC 61 flu mAb 61 MEK Inhibitor 61 Sanvar R 61 Hexvix ® 61 Neulasta R 61 NEUGENE 61 Aplidin 61 tumor antigen 61 Anticalin ® 61 Talabostat 61 potent anticancer 61 M2 subunit 61 Monoclonal antibodies 61 androgen receptor AR 61 platinum chemotherapeutic 61 sorafenib tablets 61 Pegloticase 61 Somatuline Depot 61 ABLYNX 61 novel VDA molecule 61 mitogen activated ERK kinase 61 DiLA2 61 Initiates Phase III 61 Ofatumumab 61 Presents Positive 61 GMX# 61 RNA antagonists 61 IL #p# 61 R sorafenib tablets 61 T#I [002] 61 AMEX RGN 61 Dapagliflozin 61 Liprotamase 61 Novosom 61 drug conjugates 61 Therapeutic Vaccine 61 liposome encapsulated 61 DEB# 61 Lenalidomide 61 Aplidin R 61 Regulus Therapeutics 61 Cx# [002] 61 Aflibercept 61 recombinant antibodies 61 PSMA antibody 61 JAK inhibitor 61 prodrugs 61 Anidulafungin 61 Gendux AB 61 CYP#A# CYP#D# 61 intranasal delivery 61 vinorelbine tartrate 61 Aptivus ® 61 EndoTAG 61 NASDAQ CRXL 61 Entry Inhibitor 61 Receptors GPCRs 61 dihydrofolate reductase 61 anti CD3 antibody 61 selective antagonist 61 Somatuline 61 NOD SCID mice 61 tumor specific antigen 61 effector function 61 humanised antibody 61 Vidaza azacitidine 61 OTCBB IMUC 61 PRN FDA Approves 61 cytostatic 61 GlaxoSmithKline plc GSK 61 Cytomegalovirus CMV 61 allosteric modulation 61 Creabilis Therapeutics 61 taxane derivative 61 Receives Milestone Payment 61 BXT # 61 small molecule activators 61 nilotinib Tasigna 61 docetaxel Taxotere R 61 Valortim R 61 Zenpep 61 MTP inhibitor 61 isotype 61 Copegus ribavirin 61 HepDirect prodrug 61 receptor tyrosine kinase inhibitor 61 IgG1 61 candidates Azedra TM 61 Muraglitazar 61 cancer vaccine Norelin 61 cellular immunotherapy 61 enkephalin 61 Blinatumomab 61 monoclonal antibody 61 ® bortezomib 61 virosomes 61 ALN PCS 61 Igeneon 61 Valortim ® 61 Files Investigational 61 monoclonal antibody IgG1 Mab 61 vitro assay 61 oral ferric iron 61 elbion 61 factor TNF receptor 61 enzyme inhibitor 61 TGR5 61 AKT inhibitor 61 Nanobody ® 61 Glufosfamide 61 omega interferon 61 EGFr humanized monoclonal antibody 60 ChemGenex Pharmaceuticals Limited 60 ARIKACE ™ 60 DepoVax TM 60 NasdaqGM SPPI 60 RhuDex ® 60 mGluR2 positive 60 biased ligand 60 HSP# inhibitor 60 Rhein Biotech GmbH 60 PROfusion 60 Ophthotech 60 tyrosine kinase inhibitor 60 Presents Positive Preclinical 60 radiation sensitizer 60 Aeolus Pharmaceuticals Announces 60 Receive Milestone Payment 60 PSMA ADC 60 receptor inhibiting monoclonal 60 histone deacetylase HDAC inhibitor 60 SOLVAY PHARMACEUTICALS 60 pralatrexate injection folate analogue 60 generation purine nucleoside 60 Cethromycin 60 Factor Receptor 60 vorinostat 60 Cloretazine 60 Solazed TM 60 AAV vector 60 oral ghrelin agonist 60 5 HT2A inverse 60 FLT3 60 Azedra 60 UltiMAb 60 Ixabepilone 60 Homspera TM 60 Inc. Nasdaq IMGN 60 Phase #b/#a clinical 60 Nasdaq IDRA today 60 sodium glucose cotransporter 60 humanized therapeutic 60 Crucell NV NYSE Euronext 60 Dacetuzumab 60 glycopeptides 60 5 HT4 60 recombinant hepatitis B 60 gastrointestinal stromal tumors GISTs 60 peptide antigens 60 Inc. AMEX YMI 60 trabectedin 60 retinoic acid receptor 60 AB OMXS BINV 60 inhibitor PPI 60 Viralytics 60 SPL# Gel vaginal microbicide 60 Astex Therapeutics Limited 60 Icatibant 60 CysDisplay R 60 syngeneic 60 Kosan dependence 60 HuCAL R 60 PHX# 60 AAG geldanamycin analog 60 Roche OTC RHHBY 60 Xanthus Pharmaceuticals Inc. 60 Angiolix 60 investigational oral inhibitor 60 Selective Electrochemical Tumor Ablation 60 developing TB4 60 Achieves Primary Endpoint 60 TolerRx 60 BioSante Pharmaceuticals Announces 60 immunotherapeutic 60 PEGylated anti 60 antigen sparing 60 HuMax EGFr 60 anticoagulant reversing agent 60 inhaled formulation 60 Tibotec Therapeutics division 60 ABL inhibitor 60 milatuzumab 60 kallikrein 60 EnzymeRx 60 Darinaparsin 60 Teplizumab 60 interferon lambda 60 isoform selective 60 Sanofi aventis EURONEXT SAN 60 monoclonal antibody therapeutics 60 Initiates Clinical Trial 60 Inovio Pharmaceuticals Inc. 60 trastuzumab Herceptin R 60 LentiVector 60 Pharmion Corporation 60 T#M mutation 60 TPI ASM8 60 Antibody Drug Conjugate 60 Catalyst Biosciences 60 Orphan Drug designations 60 ATryn ® GTC recombinant 60 Maxy G# 60 thymalfasin 60 cytolytic 60 activin receptor type 60 GTC NASDAQ GTCB 60 endogenous ligands 60 biologic pathway 60 flavopiridol 60 recombinant spider silk 60 oral ridaforolimus 60 platform HDL Mimetic 60 tubulin binding 60 Gammagard Liquid 60 OTCBB ADXS 60 immuno therapeutic 60 diarrhea predominant irritable 60 bortezomib Velcade 60 investigational HCV polymerase 60 Aptocine 60 EndoTAG TM -1 60 Myrexis Inc. 60 EP #R 60 Archexin 60 GVAX R 60 allogeneic cell 60 LEAPS TM 60 interferon IFN 60 Degarelix 60 cyclin dependent kinase CDK 60 Nasdaq CRXL 60 DGAT 60 novel prodrug 60 epigenetic therapies 60 DXL TM 60 polyclonal antibody 60 selective agonist 60 dasatinib Sprycel ® 60 oral picoplatin 60 novel immunomodulatory 60 Targeted Chemotherapy 60 ketolide antibiotic 60 BUPHENYL R 60 Altastaph 60 Nasdaq MITI biopharmaceutical 60 K ras mutations 60 sulfonylhydrazine class 60 OncoGel 60 HepaGam B TM 60 compound ISA# 60 Begins Dosing 60 CEQ# 60 Tyrima 60 cytidine 60 methylnaltrexone 60 annexin V 60 Curaxin 60 TYZEKA 60 Evolva 60 Archemix Corp. 60 Homspera ® 60 telomerase therapeutic 60 Platelet Derived Growth 60 Upregulation 60 Multimeric 60 PSN# [001] 60 Provectus Pharmaceuticals specializes 60 topoisomerase II inhibitor 60 Varespladib 60 experimental autoimmune encephalomyelitis 60 Fludase 60 Oracea ® 60 polymerase inhibitor 60 Pathway Inhibitor 60 ImmunoGen TAP technology 60 Nobilon 60 ESBA# 60 drug ISA# 60 plasmid DNA pDNA 60 pathophysiological effects 60 molecular chaperone regulation 60 Soliris eculizumab 60 docetaxel Taxotere ® 60 OMP #M# 60 Prodarsan R 60 visit www.genenews.com 60 Tesetaxel 60 MorphoSys proprietary 60 Adenoviral 60 HSP# inhibitors 60 immune modulators 60 arsenic trioxide injection 60 SinuNase TM 60 ASG 5ME 60 novel histone deacetylase 60 HER1 60 neurokinin 1 60 Interferons 60 Interferon Alpha 60 poly ethylene glycol PEG 60 Ampligen R 60 Ercole Biotech 60 Protexia ® 60 anticancer compound 60 Serostim ® 60 RNA antagonist 60 Macrolide 60 non porcine pancreatic 60 Alnylam Nasdaq ALNY 60 alkylating 60 Japanese Encephalitis vaccine 60 BiTE 60 G Protein Coupled 60 NovaBay Aganocide compounds 60 Zolinza 60 novel peptide 60 dasatinib Sprycel 60 orally bioavailable 60 mTOR inhibitor 60 coronary stent merged 60 Modified Vaccinia Ankara MVA 60 SUTENT ® 60 ESBATech AG 60 Anticalin R 60 Antibody Discovery 60 Piperacillin 60 hypoxia inducible factor 60 Proxinium TM 60 ADCC enhanced 60 Aflunov 60 daptomycin 60 Vaxfectin 60 novel immunotherapies 60 clade B 60 CCR1 60 recurrent metastatic ovarian cancer 60 Emezine 60 Nautilus Biotech 60 Captisol enabled 60 multi kinase inhibitor 60 cetuximab Erbitux ® 60 Receives Approvable Letter 60 erlotinib Tarceva R 60 HCV protease inhibitors 60 Aurora kinase 60 Belimumab 60 huC# DM4 60 investigational pharmacologically unique 60 PDX pralatrexate 60 Silodosin 60 neuraminidase inhibitor 60 include Healive 60 POTELLIGENT R Technology 60 cytoprotective 60 WILEX 60 Submits Response 60 LAB CGRP 60 vivo validation 60 c MET 60 Immunomedics Inc 60 bortezomib Velcade ® 60 ZEVALIN ® 60 Isavuconazole 59 Granted Orphan Drug 59 target enzyme thymidylate 59 GSK '# 59 Epigenomics proprietary 59 Pirespa 59 InterfeRx 59 product Fentanyl TAIFUN 59 Nasdaq RXII 59 oncolytic viruses 59 Cyclosporin 59 immunotoxins 59 Sunesis Pharmaceuticals 59 highly selective adenosine 59 Oxxon 59 Myocet 59 GlaxoSmithKline Biologicals SA 59 CD4 monoclonal antibody 59 MEK inhibitor 59 Activity Assay 59 Inactivated 59 essential thrombocythemia ET 59 Submits NDA 59 QUADRAMET R 59 ENMD # 59 Golimumab 59 rituximab Rituxan 59 EGFR HER2 59 alpha 2A adrenergic 59 rhMBL 59 HCV polymerase inhibitors 59 mAbs 59 SIRT1 activators 59 HuMax HepC TM 59 itraconazole Sporanox 59 TRAIL R2 59 ImClone Systems Incorporated 59 Edurant 59 chemically modified siRNA 59 EGF receptor 59 colon carcinoma 59 cyclin dependent kinase inhibitor 59 SIR Spheres 59 Evotec AG 59 Janus kinase 59 personalized immunotherapy 59 Avila Therapeutics 59 Aptamer 59 AMPK activators 59 Hepatitis C Virus HCV 59 dihydrochloride Tablets 59 HoFH 59 Submits IND 59 Announces Poster Presentations 59 Urokinase 59 solithromycin 59 Kuvan R 59 Gleevec imatinib mesylate 59 hPTH #-# 59 intranasal insulin product 59 RELISTOR ® 59 anti neoplastic 59 Tibotec Pharmaceuticals Ltd. 59 label Lipofen R 59 FermaVir 59 ADAMTS# 59 prostanoid 59 DBV Technologies 59 CD# molecule 59 galiximab 59 HER2 antibody 59 cardio renal 59 Eniluracil 59 Nycomed GmbH 59 stable nucleic acid 59 adenoviral vectors 59 Aztreonam 59 Astex Therapeutics 59 covalently bound 59 Biolipox 59 androgen receptor antagonist 59 TNF Tumor Necrosis Factor 59 staphylococcal vaccine 59 NS5B polymerase 59 prophylactic vaccines 59 Chemokine 59 Endologix Powerlink System 59 leading oral taxane 59 Imatinib mesylate 59 orally inhaled 59 orally dosed 59 Fodosine 59 novel antibody therapeutics 59 novel synthetic PEGylated 59 Oncaspar 59 Fibroblast Growth Factor Receptor 59 ganetespib 59 volociximab 59 Bortezomib 59 TREANDA 59 Wafer polifeprosan 59 ATRA IV 59 Vincent Mutel CEO 59 Alferon N 59 SynCon TM DNA 59 NS4A 59 imatinib Gleevec ® 59 Viprovex TM 59 Nasdaq ENZN 59 Transfection Reagent 59 Oral Mucositis 59 butyrylcholinesterase 59 Anavex #-# 59 Nuron Biotech 59 Xeloda ® 59 mu opioid receptor antagonist 59 Alnylam Pharma 59 introduced NEUGENE 59 oral nucleoside analogue 59 selective serotonin 2C receptor 59 BLP# Liposome Vaccine 59 AtuRNAi 59 Therapeutic Competitors 59 TGF alpha 59 bifunctional 59 Vitaxin 59 ATPace TM 59 including thyroiditis RA 59 peptides proteins 59 Axiogenesis 59 Factor VEGF 59 highly purified pasteurized 59 Irinotecan 59 non nucleoside 59 acne impetigo 59 glycosylation profile 59 EGRIFTA TM